drugset / Trial / NCT07681713
Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to confirm the treatment effects of vatiquinone on the key measures of FA disease progression.
Timeline
- Start
- 2026-08-15
- Primary completion
- 2029-03-15
- Completion
- 2029-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vatiquinone | Small molecule | 200 mg | Oral |
| Subject | Vatiquinone | Small molecule | 400 mg | Oral |